大塚製薬工場と富士通、国立がん研究センター・国立長寿医療研究センターと患者さんの低栄養リスクのAI予測サービス構築に向けた探索的共同研究を開始 Fujitsu Ltd Aug 24, 2021 10:00 JST Read More
Following Series A Financing, Scivita Medical Completes Series B Financing of Nearly RMB0.4 Billion to Accelerate the Strategic Layout of Globalization Scivita Medical Technology Co., Ltd Aug 05, 2021 12:23 JST Read More
Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma Eisai Jul 23, 2021 08:17 HKT/SGT Read More
南オーストラリア州首相、150万ドルのワクチン・免疫生物学の最先端研究所を開所 アジア太平洋地域における臨床試験に対応 Agilex Biolabs Jul 15, 2021 17:05 JST Read More
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures Adlai Nortye Jul 15, 2021 11:28 JST Read More
南オーストラリア州首相、150万ドルのワクチン・免疫生物学の最先端研究所を開所 アジア太平洋地域における臨床試験に対応 Agilex Biolabs Jul 15, 2021 07:00 JST Read More
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia Avance Clinical Jul 09, 2021 21:00 JST Read More
Eisai Launches In-house Developed Anti-insomnia Drug Dayvigo (Lemborexant) In Hong Kong Eisai Jul 01, 2021 10:43 HKT/SGT Read More
Anticancer Agent "Tazverik Tablets 200mg" (Tazemetostat Hydrobromide) Approved In Japan For EZH2 Gene Mutation-positive Follicular Lymphoma Eisai Jun 23, 2021 14:20 HKT/SGT Read More
Cofttek Announces Mass-Production and Supply of Urolithin A & B Cofttek Holding Limited Jun 15, 2021 12:00 JST Read More
Avance Clinical's USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities Avance Clinical Jun 04, 2021 09:00 JST Read More
Agilex Biolabs and Gyros Protein Technologies Partner for BioAnalysis Zone Webinar on Singlicate Analysis Agilex Biolabs May 31, 2021 14:00 JST Read More
NEC、AIによる内視鏡画像解析でバレット食道の腫瘍検知技術を開発、世界で初めて製品としてCEマークに適合 NEC Corporation May 28, 2021 10:00 JST Read More
Avance Clinical Releases Industry Survey Results at BIO Korea 2021 Avance Clinical May 27, 2021 11:00 JST Read More
Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation and Immunology for Clinical Trials Agilex Biolabs May 21, 2021 12:00 JST Read More
Anticancer Agent "Remitoro Intravenous Drip Infusion 300 microgram" (Denileukin Diftitox (Genetical Recombination)) Launched in Japan Eisai May 19, 2021 11:27 HKT/SGT Read More
Agilex Biolabs' Toxicology Tapped for SARS-CoV-2 Vaccine Research Agilex Biolabs May 17, 2021 22:00 JST Read More
富士通と武田薬品、国立がん研究センターと卵巣がん患者のペイシェントジャーニーの分析・可視化に向けた共同研究を開始 Fujitsu Ltd May 17, 2021 10:00 JST Read More
